Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Masayuki Nakashima"'
Autor:
Masayuki Nakashima, Kan Li, Qichen Chen, Sajith de Silva, Hal Li, Koji Kawakami, Qingyi Wei, Sheng Luo, Hong Zhao
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Purpose Previous randomized studies have shown a survival benefit of using regorafenib but a high rate of adverse events in unresectable colorectal cancer patients. To reduce these adverse events and improve the tolerability, we examined the
Externí odkaz:
https://doaj.org/article/dfbcb122821849f9b2914c4073aed9fd
Publikováno v:
JA Clinical Reports, Vol 9, Iss 1, Pp 1-4 (2023)
Abstract Background Selective estrogen receptor modulators (SERMs), clinically applied to osteoporosis, may have potential risk of deep venous thrombosis (DVT) and discontinuation of SERMs may be required before surgery. However, we cannot discontinu
Externí odkaz:
https://doaj.org/article/778d5a5bdc0f46518ae58a0029e64743
Publikováno v:
Pediatric Emergency Care. 39:236-241
Autor:
Satomi YOSHIDA, Masato TAKEUCHI, Sachiko TANAKA-MIZUNO, Kayoko MIZUNO, Masayuki NAKASHIMA, Toshiki FUKASAWA, Koji KAWAKAMI
Publikováno v:
Proceedings of the Japan Academy, Series B. 98:517-528
Hospital-based registry data, including patients' information collected by academic societies or government based research groups, were previously used for clinical research in Japan. Now, real-world data routinely obtained in healthcare settings are
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2083-2097
Although several studies have compared the effectiveness and safety of rivaroxaban and apixaban in patients with venous thromboembolism (VTE), direct comparison of these drugs with edoxaban is lacking.We compared the effectiveness and safety of edoxa
Publikováno v:
Supportive Care in Cancer. 31
Publikováno v:
World Journal of Surgery. 45:1717-1724
We have described the epidemiology, diagnostic modality, treatment patterns, and outcomes of acute appendicitis during pregnancy. Using a nationwide claim-based database in Japan, we analyzed the data of pregnant patients who were diagnosed with appe
Autor:
Eiji Shinozaki, Yoshinori Kagawa, Ryota Okude, Takuma Tone, Yuji Kunitomi, Masayuki Nakashima
Publikováno v:
Journal of Clinical Oncology. 41:44-44
44 Background: Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) are standard of care for refractory metastatic colorectal cancer (mCRC). Several phase II trials of FTD/TPI plus bevacizumab (BEV) have been conducted, showing promising efficacy w
Publikováno v:
Supportive Care in Cancer. 29:3951-3959
In chemotherapy-induced nausea and vomiting (CINV), the superiority of the second-generation 5-hydroxytryptamine-3 receptor antagonist (5-HT3RA) over the first-generation 5-HT3RA is shown in the delayed emesis in cycle 1. We evaluate the antiemetic e
Autor:
Eiko Takeshita, Sachio Takashima, Masayuki Nakashima, Hiromi Ishibashi, Yoriko Watanabe, Toshio Hanai, Mayumi Matsufuji, Kaori Fukui
Publikováno v:
Brain and Development. 42:231-235
An adult female patient was diagnosed with arginase 1 deficiency (ARG1-D) at 4 years of age, and had been managed with protein restriction combined with sodium benzoate therapy. Though the treatment was successful in ameliorating hyperammonemia, hype